Special Issue "Helicobacter pylori Associated Cancer"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: 31 March 2019
Prof. Dr. Yoshio Yamaoka
Department of Medicine-Gastroenterology, Baylor College of Medicine, Houston, USA
Department of Environmental and Preventive Medicine, Oita University Faculty of Medicine, Japan
Website | E-Mail
Interests: Helicobacter pylori; gastric cancer; virulence factors; epidemiology; human migration; antibiotics resistance; signal pathways; next genration sequencing
Helicobacter pylori have emerged as a major cause responsible for >80–90% of gastric cancer, which ranked the second cause of death and expenditure for cancer worldwide. H. pylori eradication has shown to provide a benefit in the decline of the incidence of the cancer over the last several decades. Although there was a great deal of effort to clarify the role, pathogenic mechanism, as well as the preventive strategies for gastric cancer since the discovery of this bacteria; understanding in these respects is still limited. Along with the development of advanced technology (bioinformatics, sequencing, molecular biological testing), an era with the new, comprehensive approaches has been ushered in to break the previous barriers and obtain the latest findings. We welcome submissions that cover all aspects associated with H. pylori-caused gastric cancer; both reviews and original papers.
Topics of interest include, but are not limited to:
- Molecular oncology (including novel H. pylori virulence factors)
- New guidelines, therapy platforms (e.g., drugs, vaccines, herbal medicines)
- Clinical trials
- Novel mutations contributing to provide novel therapeutic targets and treatment options
- Microbiome related to gastric cancer
- Gastric cancer genome-wide association study (GWAS), including bacterial GWAS
- Meta-analyses and systematic reviews
- Serum markers related to gastric cancer (e.g., pepsinogen)
- MALT lymphoma (investigation of MALT lymphoma as gastric malignancy is also welcome)
This Special Issue aims to create a place and stimulate discussion by bringing together expert opinions, as well as new scientific evidence, from across the field; thus, contributing to a through view and a deeper understanding of H. pylori-related gastric cancer.
Prof. Dr. Yamaoka Yoshio
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.